DBG
WST icon

De Burlo Group’s West Pharmaceutical WST Stock Holding History

De Burlo Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,400
Closed -$14.4M – 94
2023
Q4 		$14.4M Hold
38,400
– – 2.5% 18
2023
Q3 		$14.4M Buy
38,400
+3,500
+10% +$1.35M 2.5% 18
2023
Q2 		$13.3M Hold
34,900
– – 2.22% 19
2023
Q1 		$12.1M Buy
+34,900
New +$10.2M 2.36% 16

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

De Burlo Group's WST Position: Q1 2024 in Review

De Burlo Group sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 38,400 shares — an estimated $14.4M sold.

De Burlo Group first reported a position in WST in Q1 2023 and held it in 4 quarters. The position peaked at $14.4M in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • De Burlo Group reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • De Burlo Group sold 38,400 West Pharmaceutical shares in Q1 2024, an estimated $14.4M.
  • De Burlo Group first reported a position in West Pharmaceutical in Q1 2023 and held it in 4 quarters.
  • De Burlo Group's West Pharmaceutical position peaked at $14.4M in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on De Burlo Group's 13F filing for Q1 2024, filed 13 May 2024.